Tourmaline Bio, Inc. (TRML)
NASDAQ: TRML · Real-Time Price · USD
17.98
+0.61 (3.51%)
At close: Jul 11, 2025, 4:00 PM
17.63
-0.35 (-1.95%)
After-hours: Jul 11, 2025, 4:35 PM EDT

Tourmaline Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21
462520532--
Market Cap Growth
-33.48%-2.33%---
Enterprise Value
213238583--
Last Close Price
17.9820.2826.18--
PB Ratio
1.651.732.60--
P/TBV Ratio
1.651.732.60--
Debt / Equity Ratio
0.000.000.000.07-0.66
Quick Ratio
32.7128.9940.576.060.40
Current Ratio
33.8730.1841.766.100.40
Return on Equity (ROE)
-26.14%-28.99%-39.66%-549.77%-
Return on Assets (ROA)
-19.03%-21.60%-25.87%-266.29%-
Return on Capital (ROIC)
-19.39%-22.18%-26.60%-314.87%-
Earnings Yield
-17.94%-14.08%-7.91%--
FCF Yield
-18.19%-14.86%-5.29%--
Buyback Yield / Dilution
-144.29%-433.98%-441.28%91.94%-
Updated May 2, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q